
Leaders Bio-cancer immune yobeopje award next month for a national clinical trial is planned to be announced via press release on the 4th. Bio Leaders said that "poly-gamma-glutamic acid with solid tumor-targeted anti-cancer immune yobeopje the last two days from the Food and Drug Administration had approved a plan for clinical trials," said "next month ...Bio Leaders "held next month Phase I clinical antitumor immune yobeopje"
No comments:
Post a Comment